Chhattisgarh okays Rs 46.5 crore for new FDA lab in Nava Raipur
Chhattisgarh government sanctions Rs 46.49 crore for a new Integrated Food and Drug Testing Lab in Nava Raipur, set to boost annual sample testing capacity from 800 to 8000. Read more.
Chhattisgarh government sanctions Rs 46.49 crore for a new Integrated Food and Drug Testing Lab in Nava Raipur, set to boost annual sample testing capacity from 800 to 8000. Read more.
A massive recall of shredded cheese sold at Target, Aldi, and Walmart due to potential metal fragments. Check the list of affected brands to ensure safety.
Haryana FDA and police raided a Sirsa medical store and intercepted a vehicle, seizing thousands of illegal intoxicant tablets. Two arrested. Details on the crackdown here.
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
Leaked FDA memo claims 10 children died from COVID vaccines, sparking national safety debate. Experts question evidence as new vaccine rules promised. Read full details.
Internal FDA memo claims 10 children died from COVID-19 vaccines, sparking expert criticism. Learn about the controversy and vaccine safety data. Read more.
Goa's Town & Country Planning department mandates online building plan submissions via BPAMS from January 1. Streamline construction approvals and cut red tape. Learn more about the new digital shift!
Internal FDA memo reveals 10 children died from COVID vaccine complications as CDC withdraws autism claim. Read the shocking details and expert analysis.
FDA Commissioner Marty Makary reveals data showing 10 children died due to COVID-19 vaccination shots. Stay informed about vaccine safety updates and developments.
FDA internal review identifies 10 children who died after COVID vaccination, potentially linked to myocarditis. Dr. Vinay Prasad calls it 'profound revelation' amid policy changes.
Maharashtra FDA launches surprise inspections at Mumbai eateries, bars & restaurants until December 31. Checking food adulteration, hygiene & safety norms during Christmas & New Year celebrations.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares surged 23% in stock market debut today, outperforming grey market expectations. The ₹895-crore IPO was subscribed 93.71 times. Read full analysis.
Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.
US FDA warns about Indian-made cookware potentially leaching lead. Learn which products are affected and how to protect your family from heavy metal exposure.
Sudeep Pharma IPO allotment likely on November 26. Learn how to check allotment status via BSE, NSE, registrar. Strong 93.72x subscription signals investor confidence.
Sudeep Pharma's IPO concludes November 25 after strong第一天 response. Grey market premium hits ₹121, signaling 20% listing gains. Key dates and subscription details revealed.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
India's IPO market surges with ₹76,000 crore offerings. Excelsoft Technologies fully subscribed, Sudeep Pharma at 50%. Expert analysis on both IPOs and GMP trends revealed.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Sudeep Pharma IPO opens November 21 with price band ₹563-593 per share. Company aims to raise ₹95 crore. Learn key dates, financials, and investment details.
FDA recalls moringa supplements from Vallon Farmdirect after 11 salmonella cases. Check your products now and learn symptoms to watch for.
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.